Journals / Nöropsikiyatri Arşivi / 2012 / Cilt: 49 - Sayı: 3

Cognitive ımpairment ın relapsing-remitting multiple sclerosis

Yineleyici multipl skleroz'da kognitif bozukluk

Pages
178–182
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Discussion: Cognitive impairment is a common problem in RRMS patients and plays a major role in the quality of life.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: To assess the frequency of cognitive impairment in patients with relapsing- remitting multiple sclerosis (RRMS) using the Brief Repeatable Battery (BRB), as well as to explore the associations of cognitive impairment with demographic and clinical parameters and to evaluate its relation with physical impairment and quality of life.
📊
Key Findings & Data:Methods: Patients admitted to our hospital's Multiple Sclerosis and Demyelinating Diseases Outpatients Clinic between March and May 2010 were assessed using the BRB, Multiple Sclerosis Neuropsychological Questionnaire (MSNQ), Beck depression inventory (BDI), and the Functional Assessment of MS Quality of Life Instrument (FAMS).
💡
Conclusion & Impact:Discussion: Cognitive impairment is a common problem in RRMS patients and plays a major role in the quality of life.
🔬Design:Survey & Empirical Study
📍Scope:2010 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: To assess the frequency of cognitive impairment in patients with relapsing- remitting multiple sclerosis (RRMS) using the Brief Repeatable Battery (BRB), as well as to explore the associations of cognitive impairment with demographic and clinical parameters and to evaluate its relation with physical impairment and quality of life. Methods: Patients admitted to our hospital's Multiple Sclerosis and Demyelinating Diseases Outpatients Clinic between March and May 2010 were assessed using the BRB, Multiple Sclerosis Neuropsychological Questionnaire (MSNQ), Beck depression inventory (BDI), and the Functional Assessment of MS Quality of Life Instrument (FAMS). Results: Fifty-one patients fulfilled the study criteria. Mean test scores of the study group were PASAT 42.76±30.41; 10/36 Spatial Recall Test (SPART)-Total Learning (TL) 18.4±6.2; delayed recall (DR) 6.8±3.2; Selective Reminding Test (SRT)-TL 5.67±2.00; SRT-DR 4.67±2.00; Symbol-Digit Modalities Test (SDMT) 29.84±19.50; Word List Generation (WLG) 14.14±5.74. The mean score of MSNQ patient form was 10.27±11.95; BDI mean score was 20.20±12.17; FAMS mean score was 64.18±46.52. 41.17% of patients had cognitive impairment. Age, education level, and EDSS scores correlated with cognitive impairment (p<0.01; p<0.05; p<0,01 respectively). There was no correlation between cognitive impairment and either gender or disease duration (p>0.05; p>0.05, respectively). Patients with cognitive impairment had higher depression scores (p<0.01) and lower quality of life scores (p<0.01). Discussion: Cognitive impairment is a common problem in RRMS patients and plays a major role in the quality of life.

Özet

Amaç: Relapsing Remitting Multipl Skleroz (RRMS) hastalar›nda Brief Repeatable Battery (BRB) ile kognitif durum tayini yap›larak kognitif bozuklu€un s›kl›€›n›n de€erlendirmesi, kognitif bozukluk ile iliflkili demografik ve klinik parametrelerin incelenmesi ve kognitif bozukluk ile fiziksel özürlülük ve yaflam kalitesinin iliflkisinin de€erlendirilmesi. Yöntem: Hastanemiz Multipl Skleroz ve Demiyelinizan Hastal›klar poliklini€ine Mart-May›s 2010 tarihleri aras›nda baflvuran hastalar BRB, Multiple Sclerosis Neuropsychological Questionnairre (MSNQ), Beck depresyon envanteri (BDI), Functional Assessment of MS (FAMS) yaflam kalitesi ölçe€i ile de€erlendirildiler. Bulgular: Çal›flma kriterlerine uygun toplam 51 hasta saptand›. Çal›flma grubunun ortalama skorlar› PASAT 42,76±30,41; 10/36 uzamsal hat›rlama testi k›sa süreli bellek (KSB) 18,4±6,2, uzun süreli bellek (USB) 6,8±3,2; sözel bellek testi KSB 5,67±2,00, USB 4,67±2,00; sembol say› modalitesi testi 29,84±19,50; sözel ak›c›l›k testi 14,14±5,74’tü. MSNQ hasta formu skor ortalamas› 10,27±11,95; Beck depresyon envanteri skoru ortalamas› 20,20±12,17; FAMS skorlar› ortalamas› 64,18±46,52’ydi. Olgular›n %41,17'sinde kognitif bozukluk tespit edildi. Yafl, e€itim süresi, EDSS kognitif bozukluk ile iliflkiliyken (s›ras›yla p 0,05; p>0,05)). Kognitif bozuklu€u olan olgularda depresyon skorlar› daha yüksek (p<0,01) ve yaflam kalitesi skorlar› daha kötüydü (p<0,01). Sonuç: Kogntitif bozukluk RRMS hastalar›nda s›k karfl›lafl›lan bir sorundur ve yaflam kalitesi üzerinde önemli rol oynamaktad›r.

🔖

Cite This Article

TOPÇULAR, B., ÖZCAN, M. E., KURT, E., YANDIM, D. K., KALE, N. İ., SUTLAS, P. N., KIRBAŞ, D., BİNGÖL, A. (2012). Cognitive ımpairment ın relapsing-remitting multiple sclerosis. Nöropsikiyatri Arşivi, Cilt: 49 - Sayı: 3, 178–182. https://ajindex.com/articles/292880

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (2)

  1. Rowland LP. Meritt’ s Neurology. Tenth Edition. Lippincott Williams & Wilkins 1999. 2.Benedict RH, Cookfair D, Gavett R, Gunther M, Munschauer F, Garg N, Weinstock-Guttman B. Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS). J Int Neuropsychol Soc 2006; 12:549-558. 3.Chiaravalloti ND, DeLuca J. Cognitive impairment in multiple sclerosis. Lancet Neurol 2008; 7:1139-1151. 4.Lebrun C, Blanc F, Brassat D, Zephir H, de Seze J; CFSEP. Cognitive function in radiologically isolated syndrome. Mult Scler 2010; 16:919-925. 5.Rao SM, Leo GJ, Ellington L, Nauertz T, Bernardin L, Unverzagt F. Cognitive dysfunction in multiple sclerosis. II. Impact on employment and social functioning. Neurology 1991; 41:692-696. 6. Patti F. Cognitive impairment in multiple sclerosis. Mult Scler 2009; 15:2-8. 7. Bingöl A, Yidiz S, Tütüncü M, Demirci NO, Ahi N, Topçular B, Saip S, Siva A. Cognitive dysfunction in multiple sclerosis in a Turkish cohort. 20th Meeting of the European Neurological Society.19.06.2010 - 23.06.2010
  2. Berlin, Almanya. Poster sunumu. 8. Benedict RH, Munschauer F, Linn R, Miller C, Murphy E, Foley F, Jacobs L. Screening for multiple sclerosis cognitive impairment using a self-administered 15-item questionnaire. Mult Scler 2003; 9:95-101. 9. A. Bingol, B. Topcular, S. Yildiz et al. Validation of the Multiple Sclerosis Neuropsychological Screening Questionnaire in Turkish. 5th joint triennial congress of the european an americas committees for treatment and research in multiple sclerosis, amsterdam, The Netherlands 19.10.2011-22.10.2011. 10. Boringa JB, Lazeron RH, Reuling IE, Adèr HJ, Pfennings L, Lindeboom J, de Sonneville LM, Kalkers NF, Polman CH. The brief repeatable battery of neuropsychological tests: normative values allow application in multiple sclerosis clinical practice. Mult Scler 2001; 7:263-267. 11. Portaccio E, Goretti B, Zipoli V, Iudice A, Pina DD, Malentacchi GM, Sabatini S, Annunziata P, Falcini M, Mazzoni M, Pia Amato M; TuSCIMS Study Group. Reliability, practice effects, and change indices for Rao's Brief Repeatable Battery. Mult Scler 2010; 16:611-617. 12. Tombaugh TN. A comprehensive review of the Paced Auditory Serial Addition Test (PASAT). Arch Clin Neuropsychol 2006; 21:53-76. 13. Ehrenreich JH. Normative data for adults on a short form of theSelective Reminding Test. Psychol Rep 1995; 76:387-390. 14. Boringa JB, Lazeron RH, Reuling IE, Adèr HJ, Pfennings L, Lindeboom J, de Sonneville LM, Kalkers NF